Benzyl Glycinate Hydrochloride: A Key Intermediate for Pharmaceutical and Peptide Synthesis

Discover the essential role of Benzyl Glycinate Hydrochloride (CAS: 2462-31-9) in advancing pharmaceutical development and peptide synthesis. Explore its unique properties and diverse applications as a vital chemical intermediate.

Get a Quote & Sample

Advantages Offered by the Product

Enhanced Chemical Synthesis

Benzyl Glycinate Hydrochloride acts as a potent crosslinking inhibitor, streamlining the synthesis of complex organic molecules, which is vital for achieving high purity pharmaceutical intermediates.

Facilitates Peptide Synthesis

This compound is instrumental in peptide synthesis, promoting kinetically controlled synthesis by improving enzyme affinity and specificity, crucial for developing new therapeutic agents.

Biochemical and Pharmaceutical Applications

Its utility extends to biochemical research and pharmaceutical development, particularly in creating drugs for neurological disorders and as a potential antiviral agent, contributing to breakthroughs in healthcare.

Key Applications

Pharmaceutical Development

A key intermediate in synthesizing pharmaceuticals, especially those targeting neurological disorders and enhancing drug efficacy and specificity, supporting advanced drug development.

Peptide Synthesis

Commonly used in the production of peptides, it facilitates the formation of peptide bonds, essential for developing new therapeutic agents and complex biomolecules.

Biochemical Research

Researchers utilize it in studies related to amino acid metabolism and protein synthesis, providing crucial insights into cellular processes and disease mechanisms.

Drug Delivery Systems

Its unique structure enhances solubility and stability, making it valuable for formulating drug delivery systems to improve the bioavailability of active pharmaceutical ingredients.